UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.314

Sortiert nach

098: Effects of Selenium Supplementation on Cardiovascular Disease Incidence and Mortality: Secondary Analyses in a Randomized Clinical Trial

American journal of epidemiology, 2005-06, Vol.161 (Supplement_1), p.S25-S25

2005

Volltextzugriff (PDF)

1:45 PM, Abstract No. 191 - 90Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes

Journal of vascular and interventional radiology, 2015-02, Vol.26 (2), p.S90-S90

2015

Volltextzugriff (PDF)

1052-220 Safety and efficacy of catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A114-A114

2004

Volltextzugriff (PDF)

1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A481-A481

2004

Volltextzugriff (PDF)

11 th April: 2 nd Sunday of Easter: Acts 4.32–35; Psalm 133; 1 John 1.1–2:2; John 20.19–31

Expository times, 2021-03, Vol.132 (6), p.280-282

Donahue, John R.

2021

Volltextzugriff (PDF)

11th April: 2nd Sunday of Easter: Acts 4.32–35; Psalm 133; 1 John 1.1–2:2; John 20.19–31

Expository times, 2021-03, Vol.132 (6), p.280-282

Donahue, John R.

2021

Volltextzugriff (PDF)

12 th July: 6 th Sunday After Pentecost: Isaiah 55.10–13; Psalm 119.105–112; Romans 8.1–11; Matthew 13.1–9, 18–23

Expository times, 2020-06, Vol.131 (9), p.407-408

Donahue, John R.

2020

Volltextzugriff (PDF)

12 th November: 24 th Sunday after Pentecost: Joshua 24.1–3a, 14–25, Psalm 78.1–7, Wisdom of Solomon 6.12–16 or Amos 5.18 –24, and Wisdom of Solomon 6.17–20, Psalm 70; 1 Thessalonians 4.13–18 Matthew 25.1–13

Expository times, 2023-10, Vol.135 (1), p.23-25

Donahue, John R.

2023

Volltextzugriff (PDF)

1207P - Phase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

Annals of oncology, 2019-10, Vol.30, p.v493-v494

2019

Volltextzugriff (PDF)

1207PPhase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

12th July: 6th Sunday After Pentecost: Isaiah 55.10–13; Psalm 119.105–112; Romans 8.1–11; Matthew 13.1–9, 18–23

Expository times, 2020-06, Vol.131 (9), p.407-408

Donahue, John R.

2020

Volltextzugriff (PDF)

12th November: 24th Sunday after Pentecost: Joshua 24.1–3a, 14–25, Psalm 78.1–7, Wisdom of Solomon 6.12–16 or Amos 5.18 –24, and Wisdom of Solomon 6.17–20, Psalm 70; 1 Thessalonians 4.13–18 Matthew 25.1–13

Expository times, 2023-10, Vol.135 (1), p.23-25

Donahue, John R.

2023

Volltextzugriff (PDF)

14. The Perspectives of Gender-Diverse Youth and Caregivers Coping With Legislation Banning Gender-Affirming Medical Interventions

Journal of adolescent health, 2024-03, Vol.74 (3), p.S8-S9

2024

Volltextzugriff (PDF)

1412P Immune changes after enzalutamide (Enza) is added to androgen-deprivation therapy (ADT) in first-line metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2022-09, Vol.33, p.S1191

2022

Volltextzugriff (PDF)

A 160 MHz 32 b 0.5 W CMOS RISC microprocessor

1996 IEEE International Solid-State Circuits Conference. Digest of TEchnical Papers, ISSCC, 1996, p.214-215

1996

Volltextzugriff (PDF)

A 160-MHz, 32-b, 0.5-W CMOS RISC microprocessor

IEEE journal of solid-state circuits, 1996-11, Vol.31 (11), p.1703-1714

1996

Volltextzugriff (PDF)

164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

Annals of oncology, 2016-12, Vol.27, p.ix51-ix51

2016

Volltextzugriff (PDF)

(181) Pharmacological inhibition of methylglyoxal-associated type II painful diabetic neuropathy by the PPARγ agonist pioglitazone is sex-dependent

The journal of pain, 2017-04, Vol.18 (4), p.S21-S21

2017

Volltextzugriff (PDF)

(183) Fingolimod Reduces Neuropathic Pain Behaviors in a Mouse Model of Multiple Sclerosis by a Sphingosine-1 Phosphate Receptor 1-Dependent Inhibition of Central Sensitization in the Dorsal Horn

The journal of pain, 2017-04, Vol.18 (4), p.S22-S22

2017

Volltextzugriff (PDF)

184. Early Loss of Complexity Is a New Vital Sign—A Survival Model in 2656 Trauma Patients

The Journal of surgical research, 2008, Vol.144 (2), p.258-259

2008

Volltextzugriff (PDF)

(184) Fingolimod behaves as an agonist at sphingosine-1-phosphate receptor 1 to inhibit pain in an experimental autoimmune encephalomyelitis model of multiple sclerosis

The journal of pain, 2017-04, Vol.18 (4), p.S22-S22

2017

Volltextzugriff (PDF)

19 th March: 4 th Sunday of Lent: 1 Samuel 16.1–13, Psalm 23, Ephesians 5.8–14; John 9.1–41

Expository times, 2023-02, Vol.134 (5), p.228-230

Donahue, John R.

2023

Volltextzugriff (PDF)

19th March: 4th Sunday of Lent: 1 Samuel 16.1–13, Psalm 23, Ephesians 5.8–14; John 9.1–41

Expository times, 2023-02, Vol.134 (5), p.228-230

Donahue, John R.

2023

Volltextzugriff (PDF)

2 nd June: 2 nd Sunday after Pentecost: 1 Samuel 3.1–10, (11–20) and Psalm 139.1–6, 13-18; Deuteronomy 5.12–15 and Psalm 81.1–10; 2 Corinthians 4.5–12; Mark 2.23–3:6

Expository times, 2024-05, Vol.135 (8), p.340-342

Donahue, John R.

2024

Volltextzugriff (PDF)

1 – 25 von 2.314

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.008)
Mit Volltextzugriff
(2.062)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.418)
Life Sciences & Biomedicine
(1.080)
Humans
(706)
Female
(476)
Male
(432)
Animals
(374)
Biological And Medical Sciences
(331)
Physical Sciences
(318)
Adult
(233)
Medical Sciences
(227)
Middle Aged
(223)
Aged
(162)
Mice
(149)
Technology
(148)
Neurosciences & Neurology
(124)
Oncology
(122)
Fundamental And Applied Biological Sciences. Psychology
(120)
Surgery
(101)
Environmental Sciences
(100)
Neurosciences
(97)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

098: Effects of Selenium Supplementation on Cardiovascular Disease Incidence and Mortality: Secondary Analyses in a Randomized Clinical Trial

1:45 PM, Abstract No. 191 - 90Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes

1052-220 Safety and efficacy of catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter

1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol

11 th April: 2 nd Sunday of Easter: Acts 4.32–35; Psalm 133; 1 John 1.1–2:2; John 20.19–31

11th April: 2nd Sunday of Easter: Acts 4.32–35; Psalm 133; 1 John 1.1–2:2; John 20.19–31

12 th July: 6 th Sunday After Pentecost: Isaiah 55.10–13; Psalm 119.105–112; Romans 8.1–11; Matthew 13.1–9, 18–23

12 th November: 24 th Sunday after Pentecost: Joshua 24.1–3a, 14–25, Psalm 78.1–7, Wisdom of Solomon 6.12–16 or Amos 5.18 –24, and Wisdom of Solomon 6.17–20, Psalm 70; 1 Thessalonians 4.13–18 Matthew 25.1–13

1207P - Phase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

1207PPhase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

12th July: 6th Sunday After Pentecost: Isaiah 55.10–13; Psalm 119.105–112; Romans 8.1–11; Matthew 13.1–9, 18–23

12th November: 24th Sunday after Pentecost: Joshua 24.1–3a, 14–25, Psalm 78.1–7, Wisdom of Solomon 6.12–16 or Amos 5.18 –24, and Wisdom of Solomon 6.17–20, Psalm 70; 1 Thessalonians 4.13–18 Matthew 25.1–13

14. The Perspectives of Gender-Diverse Youth and Caregivers Coping With Legislation Banning Gender-Affirming Medical Interventions

1412P Immune changes after enzalutamide (Enza) is added to androgen-deprivation therapy (ADT) in first-line metastatic castration-resistant prostate cancer (mCRPC)

A 160 MHz 32 b 0.5 W CMOS RISC microprocessor

A 160-MHz, 32-b, 0.5-W CMOS RISC microprocessor

164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

(181) Pharmacological inhibition of methylglyoxal-associated type II painful diabetic neuropathy by the PPARγ agonist pioglitazone is sex-dependent

(183) Fingolimod Reduces Neuropathic Pain Behaviors in a Mouse Model of Multiple Sclerosis by a Sphingosine-1 Phosphate Receptor 1-Dependent Inhibition of Central Sensitization in the Dorsal Horn

184. Early Loss of Complexity Is a New Vital Sign—A Survival Model in 2656 Trauma Patients

(184) Fingolimod behaves as an agonist at sphingosine-1-phosphate receptor 1 to inhibit pain in an experimental autoimmune encephalomyelitis model of multiple sclerosis

19 th March: 4 th Sunday of Lent: 1 Samuel 16.1–13, Psalm 23, Ephesians 5.8–14; John 9.1–41

19th March: 4th Sunday of Lent: 1 Samuel 16.1–13, Psalm 23, Ephesians 5.8–14; John 9.1–41

2 nd June: 2 nd Sunday after Pentecost: 1 Samuel 3.1–10, (11–20) and Psalm 139.1–6, 13-18; Deuteronomy 5.12–15 and Psalm 81.1–10; 2 Corinthians 4.5–12; Mark 2.23–3:6

Aktive Filter

Suchergebnisse filtern